Healthcare
Live Price
Offline$132.02
-1.15% today
1Y Change
+2.49%
Window
Jun 23, 2025 → Jun 1, 2026
Coverage: 236 bars · Jun 23, 2025 → Jun 1, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Repligen Corporation (RGEN) is a Healthcare stock with a market cap of $6.61B and listed on NASDAQ. The stock last traded around $132.02 and up 2.5% across the available one-year price window (Jun 23, 2025 → Jun 1, 2026). Baseline metrics include revenue growth of +16.4%, EPS growth of +289.1%, a dividend yield of 0.0%. What stands out right now is revenue +16.4%, EPS +289.1%, free cash flow -34.1% with operating margin 7.6% and ROIC 1.5%. Valuation already assumes a fairly strong business story at P/E 135.5 and price/sales 9.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RGEN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RGEN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RGEN Max Drawdown
-40.28%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RGEN and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.